4.8 Review

Neuroscience of Behavioral and Pharmacological Treatments for Addictions

Journal

NEURON
Volume 69, Issue 4, Pages 695-712

Publisher

CELL PRESS
DOI: 10.1016/j.neuron.2011.02.009

Keywords

-

Categories

Funding

  1. Somaxon
  2. National Institutes of Health
  3. Veteran's Administration
  4. Mohegan Sun Casino
  5. National Center for Responsible Gaming
  6. National Institute on Drug Abuse [P50-DA09241, P50-DA016556, P20-DA027844, R37-DA015969, K02-DA021304, R01-DA020908, RC1-DA028279, R01-DA018647, R21 DA029445, R01-DA019039]
  7. National Institute on Alcoholism and Alcohol Abuse [RL1-AA017539]
  8. VISN 1 Mental Illness Educational, Research, and Clinical Center (MIRECC)
  9. Center of Excellence in Gambling Research from the National Center for Responsible Gaming

Ask authors/readers for more resources

Although substantial advances have been made in behavioral and pharmacological treatments for addictions, moving treatment development to the next stage may require novel ways of approaching addictions, particularly ways based on new findings regarding the neurobiological underpinnings of addictions that also assimilate and incorporate relevant information from earlier approaches. In this review, we first briefly review theoretical and biological models of addiction and then describe existing behavioral and pharmacologic therapies for the addictions within this framework. We then propose new directions for treatment development and targets that are informed by recent evidence regarding the heterogeneity of addictions and the neurobiological contributions to these disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available